Lin Sparks MSG Stock, Chelsea Therapeutics SeraCare, Regeneron, Diebold Round Out Stock Highlights Feb. 13th
Madison Square Garden, Inc. (NASDAQ:MSG): Sales of Knicks merchandise are higher than any other team in the NBA since Feb. 4, with Jeremy Lin’s jersey being the league’s top online seller in that time, as the surprising ascent of the point guard has helped the team’s record and the share price of team parent Madison Square Garden (NASDAQ:MSG), Bloomberg reported earlier. Shares of Madison Square Garden, Inc. are trading 4.94% higher today.
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP): After Chelsea Therapeutics provided an update in the wake of the release of FDA briefing documents about its Northera drug, Leerink Swann believes that questions may be raised about the drug’s overall risk profile but the firm still thinks that the drug is safe overall. The firm maintains an Outperform rating on the shares. Shares of Chelsea Therapeutics International Ltd. are trading 34.01% lower today.
SeraCare Life Sciences, Inc. (NASDAQ:SRLS): SeraCare Life Sciences announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries. Under the terms of the agreement, holders of outstanding shares of common stock of SeraCare will receive $4.00 per share, representing a 25% premium to the 30-day volume-weighted average stock price. The agreement was unanimously approved by SeraCare’s Board of Directors. If the merger is approved by shareholders, the transaction is expected to close in Q2 of 2012. Shares of SeraCare Life Sciences, Inc. are trading 9.78% higher today.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Regeneron has filed an sBLA for EYLEA in central retinal vein occlusion, or CRVO, in the U.S., and was granted a Prescription Drug User Free Act, or PDUFA, date of September 23, 2012. Bayer HealthCare plans to submit a similar regulatory application outside the U.S. in 2012 or early 2013. Shares of Regeneron Pharmaceuticals, Inc. are trading 10.98% higher today.
Diebold Incorporated (NYSE:DBD): Sees 2012 total revenue up 3%-6%. Consensus: $2.89B. Shares of Diebold Incorporated are trading 9.67% higher today.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com